COVID-19 vaccine from Anhui earns conditional approval
Share - WeChat


China has given conditional approval for a recombinant protein subunit COVID-19 vaccine developed by domestic company Anhui Zhifei Longcom Biopharmaceutical, the National Medical Products Administration said on Wednesday.
The vaccine uses purified pieces of the virus' protein to trigger an immune response. It is the first vaccine based on this technology to be approved by the top drug regulator.
In total, five COVID-19 vaccines have been approved for public use in China so far.

- SCO foreign ministers council meeting to be held in Tianjin
- Foreign officials praise Chinese gardening culture for promoting harmony
- Tianzhou 9 cargo craft transported to launch site
- Chinese scientists successfully clone yak
- Guangdong launches world's first 200,000 tons/year plastic recycling plant
- Protected green sea turtle nest found in Nansha reef